Drug Profile
Research programme: insulin-like growth factor I gene therapy - Amsterdam Molecular Therapeutics
Alternative Names: AMT-070; IGF-1 gene therapy - Amsterdam Molecular TherapeuticsLatest Information Update: 16 Jul 2012
Price :
$50
*
At a glance
- Originator Digna Biotech; University of Navarra
- Developer Amsterdam Molecular Therapeutics; University of Navarra
- Class Antihyperglycaemics; Gene therapies; Growth factors
- Mechanism of Action Gene transference; Insulin-like growth factor I stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Liver cirrhosis
Most Recent Events
- 25 Nov 2009 No development reported - Preclinical for Cirrhosis in Netherlands (Parenteral)
- 18 Nov 2009 No development reported - Preclinical for Cirrhosis in Spain (Parenteral)
- 25 May 2009 Preclinical development is ongoing